Investigators performed a preclinical study by transplanting human brain-derived-induced multipotent stem cells transcranially into post-stroke mouse brains 6 weeks after middle cerebral artery occlusion.
[Stem Cells Translational Medicine]
Transplantation of Human Brain-Derived Ischemia-Induced Multipotent Stem Cells Ameliorates Neurological Dysfunction in Mice After Stroke
